Witryna1 wrz 2024 · Immusoft was founded in 2009 and has raised more than $50 million in venture capital, according to PitchBook. In 2024, Ainsworth took over leadership from founder Matthew Scholz . Witryna14 paź 2024 · Seattle-based cell therapy startup Immusoft will collaborate with pharma giant Takeda to develop treatments targeted to the central nervous system in a deal worth potentially more than $900 ...
Immusoft Corp.:Company Profile & Technical Research,Competitor …
Witryna2 wrz 2024 · News • Sep 2, 2024. BioSpace — Immusoft Takes First-Ever Engineered B Cell Therapy into Clinic. Funding Round • Nov 29, 2024. Immusoft raised $4,000,000 / Grant from California Institute for Regenerative Medicine. Discover more funding rounds. News • Oct 13, 2024. WitrynaImmusoft Profile and History . Immusoft Corporation's mission is to treat diseases using its technology platform called Immune System Programming. The technology modifies a patient's B cells and instructs the cells to produce gene-encoded medicines. Immusoft Corporation is based in Seattle, Washington. improve office 365 excel performance
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline …
WitrynaImmusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, a novel approach that we have pioneered. ... Calif., intellectual … Rob Hayes Chief Scientific Officer . Dr. Robert Hayes is the Chief Scientific … Immusoft’s ISP approach does not require myeloablation. The other approach we … Careers; Contact © IMMUSOFT 2024 454 N 34th St., Seattle, WA 98103 … SAN FRANCISCO–(BUSINESS WIRE)– Immusoft of CA, a wholly owned … Headquarters454 N 34th St.Seattle, WA [email protected] Immusoft of … SAN FRANCISCO–(BUSINESS WIRE)– Immusoft of CA, a wholly owned … SEATTLE–(BUSINESS WIRE)–Immusoft, a clinical-stage cell therapy company … Sean Ainsworth is Immusoft’s Chief Executive Officer and Chairman of the … WitrynaImmusoft Corp. Sean AINSWORTH; B Cells as Biofactories. Immusoft is a clinical stage cell therapy company based in Seattle, WA, that has developed an innovative approach to gene delivery, known as Immune System Programming. ISP uses a non-viral integrating gene delivery system - the Sleeping Beauty Transposon System - that … Witryna13 paź 2024 · Immusoft is a cell therapy company focused on developing novel therapies for rare diseases using a sustained delivery of protein therapeutics from a … improve nursing staffing